Developing zebrafish disease models for in vivo small molecule screens
- PMID: 30928773
- PMCID: PMC6800242
- DOI: 10.1016/j.cbpa.2019.02.005
Developing zebrafish disease models for in vivo small molecule screens
Abstract
The zebrafish is a model organism that allows in vivo studies to be performed at a scale usually restricted to in vitro studies. As such, the zebrafish is well suited to in vivo screens, in which thousands of small molecules are tested for their ability to modify disease phenotypes in zebrafish disease models. Numerous approaches have been developed for modeling human diseases in zebrafish, including mutagenesis, transgenesis, pharmacological approaches, wounding, and exposure to infectious or cancerous agents. We review the various strategies for modeling human diseases in zebrafish and discuss important considerations when developing zebrafish models for use in in vivo small molecule screens.
Copyright © 2019 Elsevier Ltd. All rights reserved.
Figures
References
-
- MacRae CA, Peterson RT: Zebrafish as tools for drug discovery. Nat Rev Drug Discov (2015) 14(10):721–731. - PubMed
-
- Howe K, Clark MD, Torroja CF, Torrance J, Berthelot C, Muffato M, Collins JE, Humphray S, McLaren K, Matthews L, McLaren S et al. The zebrafish reference genome sequence and its relationship to the human genome. Nature (2013) 496(7446):498–503. - PMC - PubMed
-
Sequencing, assembly, and annotaiton of the zebrafish genome has helped highlight the degree of similarity between zebrafish and human genomes, including the existence of zebrafish orthologs for 82% of human disease-related genes.
-
- Zhong TP, Rosenberg M, Mohideen MA, Weinstein B, Fishman MC: Gridlock, an hlh gene required for assembly of the aorta in zebrafish. Science (2000) 287(5459):1820–1824. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
